IND Swift Laboratories

IND Swift Laboratories Current Assets

The Current Assets of IND Swift Laboratories (INDSWFTLAB.NS) as of Oct 16, 2026 is 7.78 B INR. In the previous year, Current Assets was 9.58 B INR — a change of -18.77% (lower).

Current Assets

7.78 BINR

YoY

-18.77%

Last updated:

Current Assets of IND Swift Laboratories is 2026 7.78 B INR. Current Assets of IND Swift Laboratories was 2025 9.58 B INR. It decreases by -18.77% lower compared to the previous year.

The IND Swift Laboratories Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
8.89 B INR
Jan 1, 2020
9.07 B INR
Jan 1, 2021
9.56 B INR
Jan 1, 2022
11.46 B INR
Jan 1, 2023
13.04 B INR
Jan 1, 2024
10.04 B INR
Jan 1, 2025
9.58 B INR
Jan 1, 2026
7.78 B INR
The IND Swift Laboratories Current Assets history
YEARCurrent AssetsYoY
7.78 BINR-18.77%
9.58 BINR-4.55%
10.04 BINR-23.03%
13.04 BINR+13.76%
11.46 BINR+19.94%
9.56 BINR+5.36%
9.07 BINR+2.02%
8.89 BINR+5.56%
8.42 BINR+4.43%
8.07 BINR-12.87%
9.26 BINR-7.56%
10.02 BINR-5.93%
10.65 BINR-32.87%
15.86 BINR+16.00%
13.67 BINR+13.35%
12.06 BINR+127.87%
5.29 BINR+32.29%
4.00 BINR-21.84%
5.12 BINR+102.88%
2.52 BINR+22.94%
2.05 BINR+34.17%
1.53 BINR+64.52%
930.00 MINR+20.47%
772.00 MINR+30.19%
593.00 MINR+10.43%
537.00 MINR+23.73%
434.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

IND Swift Laboratories Stock analysis

What does IND Swift Laboratories do? IND Swift Laboratories Ltd is a pharmaceutical company based in Chandigarh, India, operating within the healthcare sector. The company specializes in the manufacturing, development, and marketing of pharmaceutical ingredients, including intermediates and formulations. It employs 1,496 full-time employees and went public via an IPO on March 15, 2002. IND Swift Laboratories serves as an API (Active Pharmaceutical Ingredient) partner for various organizations in both generic and innovative pharmaceutical domains. The company provides reference standards and impurities for multiple active pharmaceutical ingredients (APIs), adhering to standards such as the British Pharmacopoeia (BP) and European Pharmacopoeia (EP). Its product portfolio includes over 25 APIs, with all impurities supplied alongside comprehensive documentation, including Certificates of Analysis and Material Safety Data Sheets (MSDS). The firm maintains a research center spanning 40,000 square feet, dedicated to developing process technology for APIs across various therapeutic categories. The company's website is www.indswiftlabs.com, and it operates under the ticker symbol INDSWFTLAB.NS with ISIN INE915B01019. IND Swift Laboratories focuses on supplying high-quality pharmaceutical components to support global pharmaceutical manufacturing needs. IND Swift Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IND Swift Laboratories stock

Current Assets of IND Swift Laboratories is 7.78 B INR in 2026.

Current Assets of IND Swift Laboratories changed from 9.58 B INR to 7.78 B INR, representing a -18.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets IND Swift Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's IND Swift Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — IND Swift Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — IND Swift Laboratories